XML 70 R55.htm IDEA: XBRL DOCUMENT v3.25.1
Schedule I - Condensed Financial Information of the Registrant (Parent Company) (Tables)
 12 Months Ended
Dec. 31, 2024
Notes Tables  
Condensed Balance Sheet [Table Text Block]

(in thousands)

  

December 31, 2024

    

December 31, 2023

  
                 

Assets

                

Investments in subsidiaries

   $ 12,851     $ 20,325  

Cash and cash equivalents

     56       2,058  

Other assets

     3,992       5,339  

Total Assets

   $ 16,899     $ 27,722  

Liabilities and Shareholders' Equity

                

Liabilities:

                

Accrued expenses and other liabilities

   $ 236     $ 13  

Total Liabilities

     236       13  

Redeemable Class B preferred stock

     8,250       —  

Shareholders' Equity:

                

Common stock

     —       —  

Additional paid-in capital

     376,784       379,813  

Treasury stock, at cost

     (6,200 )     (3,696 )

Accumulated deficit

     (361,453 )     (346,868 )

Accumulated other comprehensive loss

     (718 )     (1,540 )

Shareholders' equity attributable to common shareholders

     8,413       27,709  

Total Liabilities, Class B preferred stock and Shareholders' Equity

   $ 16,899     $ 27,722  
Condensed Income Statement [Table Text Block]

(in thousands)

  

Years ended December 31,

  
   

2024

    

2023

  

Other expenses, net:

                

General and administrative expenses

   $ (98 )   $ (1,990 )

Non-operating other expense

     (1 )     (3 )

Total other expenses, net

     (99 )     (1,993 )

Loss from continuing operations before income tax benefit and equity in (loss) income of subsidiaries

     (99 )     (1,993 )

Income tax benefit

     (439 )     (1,331 )

Equity in (loss) income of subsidiaries

     (8,635 )     24,674  

Net (loss) income

   $ (8,295 )   $ 24,012  
Condensed Statement of Comprehensive Income [Table Text Block]

(in thousands)

  

Years ended December 31,

  
   

2024

    

2023

  
                 

Net (loss) income

   $ (8,295 )   $ 24,012  

Other comprehensive income (loss), net of taxes(1):

                

Unrealized losses on available-for-sale investments:

                

Unrealized losses arising during the period

     —       —  

Reclassification adjustment for amounts included in net income

     —       —  

Other comprehensive loss - parent only

     —       —  

Equity in other comprehensive income (loss) of subsidiaries

     861       (28,115 )

Other comprehensive income (loss), net of taxes(1):

     861       (28,115 )

Comprehensive loss

   $ (7,434 )   $ (4,103 )
Condensed Cash Flow Statement [Table Text Block]

(in thousands)

  

Years ended December 31,

  
   

2024

    

2023

  

Cash provided by (used in):

                

Operating activities:

                

Net (loss) income

   $ (8,295 )   $ 24,012  

Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:

                

Equity in net loss (income) of subsidiaries

     8,635       (24,674 )

Stock-based compensation expense, net of forfeitures

     (1,459 )     509  

Change in other assets

     1,347       (4,026 )

Change in accrued expenses and other liabilities

     57       (3,193 )

Net cash provided by (used in) operating activities

     285       (7,372 )

Investing activities:

                

Net cash from investing activities

     —       —  

Financing activities:

                

Proceeds from exercise of warrants

     —       16,658  

Cash paid for repurchase of warrants

     —       (4,031 )

Proceeds from issuance of preferred stock

     8,250       —  

Cash paid for repurchase of common stock

     (2,504 )     (3,204 )

Payment of preferred stock dividends

     (13 )     —  

Capital contributions to subsidiaries

     (8,020 )     (25 )

Net cash (used in) provided by financing activities

     (2,287 )     9,398  

Net (decrease) increase in cash and cash equivalents

     (2,002 )     2,026  

Cash and cash equivalents at beginning of period

     2,058       32  

Cash and cash equivalents at end of period

   $ 56     $ 2,058